These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


410 related items for PubMed ID: 11081315

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2258-63. PubMed ID: 16360055
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ, PainFREE Rx II Investigators.
    J Am Coll Cardiol; 2005 Jul 19; 46(2):310-6. PubMed ID: 16022960
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation.
    Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):850-7. PubMed ID: 16139136
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy.
    Cha YM, Gersh BJ, Maron BJ, Boriani G, Spirito P, Hodge DO, Weivoda PL, Trusty JM, Friedman PA, Hammill SC, Rea RF, Shen WK.
    J Cardiovasc Electrophysiol; 2007 May 06; 18(5):483-7. PubMed ID: 17343723
    [Abstract] [Full Text] [Related]

  • 32. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D.
    JACC Heart Fail; 2014 Dec 06; 2(6):611-9. PubMed ID: 25282033
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.
    Europace; 2008 Mar 06; 10(3):358-63. PubMed ID: 18308756
    [Abstract] [Full Text] [Related]

  • 39. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.
    Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD, Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group.
    Circulation; 2004 Dec 21; 110(25):3760-5. PubMed ID: 15583079
    [Abstract] [Full Text] [Related]

  • 40. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy.
    López Gil M, Arribas F, Cosío FG.
    Europace; 2000 Oct 21; 2(4):327-32. PubMed ID: 11194600
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.